Polycomb Repressive Complex 2 Is a Barrier to KRAS-Driven Inflammation and Epithelial-Mesenchymal Transition in Non-Small-Cell Lung Cancer
Michela Serresi, Gaetano Gargiulo, Natalie Proost, Bjorn Siteur, Matteo Cesaroni, Martijn Koppens, Huafeng Xie, Kate D Sutherland, Danielle Hulsman, Elisabetta Citterio, Stuart Orkin, Anton Berns, Maarten van Lohuizen
Cancer Cell | CELL PRESS | Published : 2016
Awarded by Dutch Cancer Society (KWF)
We are grateful to M. Melis for Luminex experiments and I. de Rink for help with sequencing data. We thank J.-Y. Song for pathology; E. Tanger, M. Cozijnsen, and NKI Genomics Core, Microscopy, FACS, and Animal Pathology and Animal Facilities for technical assistance; and C. Creasy (GSK) for the GSK126 compound. We also thank F. Scheeren and E. Guccione, for critically reading the manuscript, M. Ogrunc and A. Gruszka for manuscript proofreading, and A. Sparmann for advice. This work was supported by grants from the European Union Marie Curie Actions (G.G.), the Fondazione Lorini (G.G.), the Dutch Cancer Society (KWF; NKI 2013-61093 and NKI 2014-7208; G.G. and M.v.L.) and the Netherlands Organization for Scientific Research (NWO) to Cancer Genomics Netherlands (CGC.nl; M.v.L.). This work is dedicated to the memory of M.S.'s father, Luigi Serresi.